4//SEC Filing
Piekos Brian 4
Accession 0001213900-21-021524
CIK 0001816736other
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 4:06 PM ET
Size
5.6 KB
Accession
0001213900-21-021524
Insider Transaction Report
Form 4
Piekos Brian
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-04-12+377,734→ 377,734 totalExercise: $12.59Exp: 2031-04-11→ Common Stock (377,734 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a period of four years from the Vesting Start Date, April 12, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, provided that as of each such date the Grantee remains in a business relationship with the Company.
Documents
Issuer
Gemini Therapeutics, Inc. /DE
CIK 0001816736
Entity typeother
Related Parties
1- filerCIK 0001815308
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 4:06 PM ET
- Size
- 5.6 KB